Products
B2B Zone
4th Tumor Myeloid Targeting Therapies Summit 2024
4th Tumor Myeloid Targeting Therapies Summit 2024
Conferences

4th Tumor Myeloid Targeting Therapies Summit 2024

By

Hanson Wade

2 Followers
11 Jun 2024 - 13 Jun 2024
Free Registration

Event Details

4th Tumor Myeloid Targeting Therapies Summit 2024

The landscape of innate immune cells is rapidly advancing towards clinical applications. Multiple published studies in the last year repeatedly affirm that targeting myeloid cells rather than the cancer cells themselves can shrink tumors, further providing confidence in their potential as a clinically effective therapeutic.

The 4th Annual Tumor Myeloid Targeting Therapies Summit captures this progressive momentum and is welcoming innate immunity experts from
biopharma and academia to showcase novel clinical practices across multiple myeloid subsets.
As the field extends beyond macrophages, this meeting will also cover MDSCs, neutrophils and dendritic cells and delves into their intricate interactions within the TME for treating resistance in a range of cancers.

Hear from the likes of MD Anderson, Gilead Sciences, Onchilles Pharma, DEM Biopharma, NGM Biopharma and many more to uncover translational lessons learned when using combination therapies for tumor eradication, discover novel targets to assess the efficacy of myeloid cell-based interventions, decipher the complexities of the TME in liquid and solid tumors and more in this year's agenda.

As we stand at the forefront of ground-breaking discoveries, prioritizing collaboration becomes essential to unveil the most effective myeloid-based therapies while addressing key challenges that stand in the way of their development. Join your peers in the innate immunity field to take part in strategic networking and scientific knowledge exchange at this must-attend event.


URLs:
Website: https://go.evvnt.com/2219781-0?pid=10018
Tickets: https://go.evvnt.com/2219781-2?pid=10018
Brochure: https://go.evvnt.com/2219781-3?pid=10018

Prices:
Conference Only - Drug Developer: USD 2999.00,
Conference + Pre - Conference Workshop Day - Drug Developer: USD 4197.00,
Conference Only - Service Provider: USD 3699.00,
Conference + Pre - Conference Workshop Day - Service Provider: USD 5097.00,
Conference Only - Academic: USD 2199.00,
Conference + Pre - Conference Workshop Day - Academic: USD 2897.00

Speakers: Akshata Udyavar, Senior Director, Actym Therapeutics, Peter Ellmark, CSO, Alligator Bioscience, Stephanie Casey Parks, Principal Scientist, Amgen, Mokkram Hossain, Senior Scientist, AstraZeneca, Michael Alonso, Vice President, Immunology and Pharmacology, Bolt Biotherapeutics, Ananta Paine, Biomarker Specialist, Boston University, Daniel Blumenthal, Associate Director, Carisma Therapeutics, David Reardon, Clinical Director and Professor of Medicine, Dana-Farber Cancer Institute, Kipp Weiskopf, Co-founder/Fellow, DEM Biopharma, Aditya Murthy, Director, Immuno-oncology, Gilead Sciences, Roshan Kumar, Senior Director of External Innovations, HiFiBio Therapeutics, Miriam Merad, Director and Professor, Icahn School of Medicine at Mount Sinai, Charlene Liao, President and CEO, Immune-Onc Therapeutics, Osiris M Belaunzaran, CSO Oncology, Immunos Therapeutics, Nagy Habib, Professorv Imperial College London, Pravesh Gupta, Odyssey Fellow MD, Anderson Cancer Center, Barbara Platzer, Associate Director, Novartis, Ravindra Gujar, Senior Scientist, Onchilles Pharma, Aram Mangasarian, CEO, TME Pharma, Jashodeep Datta, Assistant Professor, University of Miami, Jean Tchervenkov, Professor of Surgery, University of McGill , Jonathan Cools-Lartigue, Associate Professor, University of McGill

Entry Fees

Free Registration

Categories

Event Frequency

One Time

Event Timings

(GMT-4:00) Eastern Time (US and Canada)
08:00 AM - 05:00 PM (Jun 11, Jun 12, Jun 13) (Public)

Speakers

Akshata Udyavar
Akshata Udyavar
Senior Director, Actym Therapeutics
Peter Ellmark
Peter Ellmark
CSO, Alligator Bioscience
Stephanie Casey Parks
Stephanie Casey Parks
Principal Scientist, Amgen
Mokkram Hossain
Mokkram Hossain
Senior Scientist, AstraZeneca

Comments on 4th Tumor Myeloid Targeting Therapies Summit 2024

You must to write a comment.

Peoples Interested in Visit

0 Peoples Interested to Visit

Event Location

Hilton Boston Back Bay
40, Dalton Street, Back Bay, Boston ,
Boston 02115, Massachusetts, United States
Official Link :

More Events By Organizer

6th Annual TIL Therapies Summit
6th Annual TIL Therapies Summit
22
Oct
2024

6th Annual TIL Therapies Summit

Suffolk County, United States
Free
Conferences
3rd Operationalise: Early Access Programmes Summit Europe
3rd Operationalise: Early Access Programmes Summit Europe
07
Oct
2024
Free
Conferences
ADC Pharmacokinetics and Clinical Pharmacology Summit
ADC Pharmacokinetics and Clinical Pharmacology Summit
08
Oct
2024
Free
Conferences
Carbon Accounting in Agricultural Supply Chains
Carbon Accounting in Agricultural Supply Chains
12
Nov
2024
Free
Conferences
4th TGF-B Targeted Drug Development Summit
4th TGF-B Targeted Drug Development Summit
15
Oct
2024
Free
Conferences
7th TPD and Induced Proximity Summit
7th TPD and Induced Proximity Summit
28
Oct
2024

7th TPD and Induced Proximity Summit

Suffolk County, United States
Free
Conferences

Similar Events

7th Annual Liquid Biopsy for Precision Oncology Summit
7th Annual Liquid Biopsy for Precision Oncology Summit
14
Feb
2023
Free
Conferences
13th World Clinical Biomarkers and CDx Boston 2023
13th World Clinical Biomarkers and CDx Boston 2023
05
Sep
2023
Free
Conferences
5th Gene Therapy for Neurological Disorders 2023
5th Gene Therapy for Neurological Disorders 2023
06
Nov
2023
Free
Conferences
Benefits of Signin
  • Publish Your Event for Free
  • Find Upcoming Events Near By
  • Grow Your B2B Network
  • Fix B2B Meeting Online/Event
  • Showcase Products to Right People